Literature DB >> 22547735

Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy.

Lanfranco Fattorini, Giovanni Battista Migliori, Antonio Cassone, Alessandro Mustazzolu, Giovanni Piccaro, Perla Filippini, Daniela Maria Cirillo, Emanuele Borroni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22547735     DOI： 10.1183/09031936.00129011

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa.

Authors:  Y Gardee; A W Dreyer; H J Koornhof; S V Omar; P da Silva; Z Bhyat; N A Ismail
Journal:  J Clin Microbiol       Date:  2016-12-14       Impact factor: 5.948

2.  Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.

Authors:  Alessandro Mustazzolu; Angelo Iacobino; Federico Giannoni; Claudio Piersimoni; Lanfranco Fattorini
Journal:  J Clin Microbiol       Date:  2017-09-13       Impact factor: 5.948

3.  First evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countries.

Authors:  Doris Hillemann; Sven Hoffner; Daniela Cirillo; Francis Drobniewski; Elvira Richter; Sabine Rüsch-Gerdes
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.